3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
45
Stomach Neoplasms
23
Pancreatic Neoplasms
22
Rectal Neoplasms
16
Esophageal Neoplasms
14
Adenocarcinoma Of Esophagus
14
Colonic Neoplasms
13
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Neoplasm Metastasis
10
Urinary Bladder Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Esophageal Squamous Cell Carcinoma
7
Adenocarcinoma
7
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Ovarian Neoplasms
5
Cholangiocarcinoma
5
Lung Neoplasms
4
Endometrial Neoplasms
4
Carcinoma, Hepatocellular
4
Carcinoma
4
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Breast Neoplasms
3
Biliary Tract Neoplasms
3
Advanced Solid Tumors
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Oropharyngeal Neoplasms
2
Melanoma
2
Interventions
tremelimumab
2
pembrolizumab
2
Nivolumab
2
Carboplatin
2
poly ICLC
1
osimertinib
1
lenvatinib
1
durvalumab
1
cemiplimab
1
balstilimab
1
Vascular Endothelial Growth Factor A
1
Peptides
1
Pemetrexed
1
Paclitaxel
1
Ipilimumab
1
Docetaxel
1
Blood Specimen Collection
1
Antibodies, Bispecific
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Insulin-Dependent, 12
×
Fluorouracil
×
90 days
×
Clear all
No trials found.